康乃德生物医药2023年度报告

TableofContents UNITEDSTATES SECURITIESANDEXCHANGECOMMISSION Washington,D.C.20549 FORM20-F oREGISTRATIONSTATEMENTPURSUANTTOSECTION12(b)OR(g)OFTHESECURITIESEXCHANGEACTOF1934 OR xANNUALREPORTPURSUANTTOSECTION13OR15(d)OFTHE SECURITIESEXCHANGEACTOF1934 ForthefiscalyearendedDecember31,2023OR oTRANSITIONREPORTPURSUANTTOSECTION13or15(d)OFTHE SECURITIESEXCHANGEACTOF1934 OR oSHELLCOMPANYREPORTPURSUANTTOSECTION13OR15(d)OFTHESECURITIESEXCHANGEACTOF1934 Dateofeventrequiringthisshellcompanyreport:Notapplicable. Commissionfilenumber001-40212 ConnectBiopharmaHoldingsLimited (ExactnameofRegistrantasspecifiedinitscharter) Notapplicable (TranslationofRegistrant’snameintoEnglish) CaymanIslands (Jurisdictionofincorporationororganization)12265ElCaminoReal,Suite350 SanDiego,CA92130,USA(Addressofprincipalexecutiveoffices) Dr.ZhengWei 12265ElCaminoReal,Suite350SanDiego,CA92130,USA Tel:+1(858)727-1040 Fax:+1(858)614-7007 (Name,Telephone,Emailand/orFacsimilenumberandAddressofCompanyContactPerson)SecuritiesregisteredortoberegisteredpursuanttoSection12(b)oftheAct. Nameofeachexchangeonwhich TitleofeachclassTradingSymbol(s)registered AmericanDepositaryShares,eachrepresentingoneOrdinaryShare,parvalue$0.000174perShare CNTBTheNasdaqGlobalMarket SecuritiesregisteredortoberegisteredpursuanttoSection12(g)oftheAct. None(TitleofClass) SecuritiesforwhichthereisareportingobligationpursuanttoSection15(d)oftheAct. None(TitleofClass) Indicatethenumberofoutstandingsharesofeachoftheissuer’sclassesofcapitalorcommonstockasofthecloseoftheperiodcoveredbytheannualreport. 55,102,954OrdinaryShares,parvalue$0.000174perShare Indicatebycheckmarkiftheregistrantisawell-knownseasonedissuer,asdefinedinRule405oftheSecuritiesAct.YesoNox Ifthisreportisanannualortransitionreport,indicatebycheckmarkiftheregistrantisnotrequiredtofilereportspursuanttoSection13or15(d)oftheSecuritiesExchangeActof1934.YesoNox Note–CheckingtheboxabovewillnotrelieveanyregistrantrequiredtofilereportspursuanttoSection13or15(d)oftheSecuritiesExchangeActof1934fromtheirobligationsunderthoseSections. Indicatebycheckmarkwhethertheregistrant(1)hasfiledallreportsrequiredtobefiledbySection13or15(d)oftheSecuritiesExchangeActof1934duringthepreceding12months(orforsuchshorterperiodthattheregistrantwasrequiredtofilesuchreports),and(2)hasbeensubjecttosuchfilingrequirementsforthepast90days.YesxNoo IndicatebycheckmarkwhethertheregistranthassubmittedelectronicallyeveryInteractiveDataFilerequiredtobesubmittedpursuanttoRule405ofRegulationS-T(§232.405ofthischapter)duringthepreceding12months(orforsuchshorterperiodthattheregistrantwasrequiredtosubmitsuchfiles).YesxNoo Indicatebycheckmarkwhethertheregistrantisalargeacceleratedfiler,anacceleratedfiler,anon-acceleratedfiler,oranemerginggrowthcompany.Seedefinitionsof“largeacceleratedfiler,”“acceleratedfiler,”and“emerginggrowthcompany”inRule12b-2oftheExchangeAct. LargeAcceleratedFileroAcceleratedFilero Non-AcceleratedFilerxEmerginggrowthcompanyx IfanemerginggrowthcompanythatpreparesitsfinancialstatementsinaccordancewithU.S.GAAP,indicatebycheckmarkiftheregistranthaselectednottousetheextendedtransitionperiodforcomplyingwithanyneworrevisedfinancialaccountingstandards†providedpursuanttoSection13(a)oftheExchangeAct.o †Theterm“neworrevisedfinancialaccountingstandard”referstoanyupdateissuedbytheFinancialAccountingStandardsBoardtoitsAccountingStandardsCodificationafterApril5,2012. Indicatebycheckmarkwhethertheregistranthasfiledareportonandattestationtoitsmanagement’sassessmentoftheeffectivenessofitsinternalcontroloverfinancialreportingunderSection404(b)oftheSarbanes-OxleyAct(15U.S.C.7262(b))bytheregisteredpublicaccountingfirmthatpreparedorissueditsauditreport.o IfsecuritiesareregisteredpursuanttoSection12(b)oftheAct,indicatebycheckmarkwhetherthefinancialstatementsoftheregistrantincludedinthefilingreflectthecorrectionofanerrortopreviouslyissuedfinancialstatements.o Indicatebycheckmarkwhetheranyofthoseerrorcorrectionsarerestatementsthatrequiredarecoveryanalysisofincentive-basedcompensationreceivedbyanyoftheregistrant’sexecutiveofficersduringtherelevantrecoveryperiodpursuantto§240.10D-1(b).o Indicatebycheckmarkwhichbasisofaccountingtheregistranthasusedtopreparethefinancialstatementsincludedinthisfiling: U.S.GAAPoInternationalFinancialReportingStandardsasissued bytheInternationalAccountingStandardsBoardx Othero If“Other”hasbeencheckedinresponsetothepreviousquestion,indicatebycheckmarkwhichfinancialstatementitemtheregistranthaselectedtofollow.Item17oItem18o Ifthisisanannualreport,indicatebycheckmarkwhethertheregistrantisashellcompany(asdefinedinRule12b-2oftheExchangeAct).YesoNox TableofContents TableofContents ABOUTTHISANNUALREPORT1 PRESENTATIONOFFINANCIALINFORMATION1 EXCHANGERATES1 CAUTIONARYSTATEMENTREGARDINGFORWARD-LOOKINGSTATEMENTS2 PARTI4 ITEM1.IDENTITYOFDIRECTORS,SENIORMANAGEMENTANDADVISORS.4 ITEM2.OFFERSTATISTICSANDEXPECTEDTIMETABLE.4 ITEM3.KEYINFORMATION.4 A.[Reserved]4 B.CapitalizationandIndebtedness4 C.ReasonsfortheOfferandUseofProceeds4 D.RiskFactors4 ITEM4.INFORMATIONON